1988
DOI: 10.1021/bi00414a048
|View full text |Cite
|
Sign up to set email alerts
|

Cholinergic synaptic vesicle heterogeneity: evidence for regulation of acetylcholine transport

Abstract: Crude cholinergic synaptic vesicles from a homogenate of the electric organ of Torpedo californica were centrifuged to equilibrium in an isosmotic sucrose density gradient. The classical VP1 synaptic vesicles banding at 1.055 g/mL actively transported [3H]acetylcholine (AcCh). An organelle banding at about 1.071 g/mL transported even more [3H]AcCh. Transport by both organelles was inhibited by the known AcCh storage blockers trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol, formerly AH5183) and nigericin. R… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
21
0

Year Published

1989
1989
2010
2010

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 34 publications
(23 citation statements)
references
References 30 publications
2
21
0
Order By: Relevance
“…This suggestion is supported by the finding (Gracz, Wang & Parsons, 1988) that VP1 and VP2 vesicles at the Torpedo electric organ, as well as having different ACh and ATP contents and transport activities, also express a different number of (-)-vesamicol binding sites. As it is unlikely that the integral protein to which (-)-vesamicol binds is actually removed and replaced during either vesicle exocytosis, recycling or refiling, Gracz et al (1988) suggested that the protein containing the (-)-vesamicol binding site plays a role in the regulation of the vesicular transport of ACh. It therefore seems possible that (-vesamicol inhibits the uptake of ACh into vesicles by acting on this regulatory system.…”
Section: Discussionmentioning
confidence: 64%
“…This suggestion is supported by the finding (Gracz, Wang & Parsons, 1988) that VP1 and VP2 vesicles at the Torpedo electric organ, as well as having different ACh and ATP contents and transport activities, also express a different number of (-)-vesamicol binding sites. As it is unlikely that the integral protein to which (-)-vesamicol binds is actually removed and replaced during either vesicle exocytosis, recycling or refiling, Gracz et al (1988) suggested that the protein containing the (-)-vesamicol binding site plays a role in the regulation of the vesicular transport of ACh. It therefore seems possible that (-vesamicol inhibits the uptake of ACh into vesicles by acting on this regulatory system.…”
Section: Discussionmentioning
confidence: 64%
“…Increasing the ratio of reserve pool to releasable pool vesicles would reduce the amount of ACh available for release during lighter periods of stimulation and thereby reduce overall stimulation if the mobilization of reserve pool vesicles is too slow to compensate. The two hypotheses we present to explain high and low CMAP values may interrelate as newly synthesized ACh is thought to preferentially load more rapidly recycling vesicles (Gracz et al, 1988, Bonzelius and Zimmermann, 1990). Possibly, only in mice where there is a sufficiently large population of recycling vesicles can elevated ACh synthesis “win out” and result in an elevation in cholinergic signaling.…”
Section: Discussionmentioning
confidence: 85%
“…The lead compound vesamicol binds to the cytoplasmic side (14) with an equilibrium dissociation constant ( K D ) value of ~5nM (15). Binding sometimes exhibits positive cooperativity, but this is a variable observation (16, 17). Vesamicol analogs inhibit transport noncompetitively (16, 18), but they apparently need bind only a fraction of VAChT in isolated vesicles to inhibit fully (19).…”
Section: The Physical Chemistry Of Uptake and Storagementioning
confidence: 99%